The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults. The approval was supported by data from th ...
The following is a summary of “Association between impaired brachial flow-mediated dilation and early neurological ...
The following is a summary of “Association of blood pressure parameters on early neurological deterioration in patients with ...
National Institutes of Health Fellows United Recording Secretary Matt Brown joins The Weekend as the Trump administration purges hundreds or even thousands of employees at federal health agencies ...
Demographic, clinical and radiological factors associated with lower EQ-5D utility score were age, randomisation outside of China, antithrombotic use, high baseline National Institutes of Health ...
7 Similar and significant effects of the intervention were seen for the secondary outcomes of infarct volume at 24–48 h and National Institutes of Health Stroke Scale score at 24 h and 72 h, but not ...
The median score on the National Institutes of Health Stroke Scale (range, 0 to 42, with higher scores indicating more severe symptoms) at admission was 6 (interquartile range, 5 to 9).
The median NIH Stroke Scale score was 6 at admission ... Mocco, MD, of Mount Sinai Health System in New York City, characterized the DISTAL and ESCAPE-MeVO cohorts as being older and having ...
Objective Many studies examining stroke outcomes focus on more severe strokes or have short follow-up periods, so the long-term outcomes post-minor ischaemic stroke are unclear. Methods We recruited ...
As President Trump takes the reins of the federal government, one of the agencies in turmoil is the National Institutes of Health — the world's leading public funder of biomedical research. The new ...
23 The hierarchical mRS scores range from 0 to 6 ... recurrent stroke and change in calculated National Institutes of Health Stroke Scale (NIHSS). Late secondary outcomes include reported changes in ...